Assenagon Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $117K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $646K | Sell |
|
|||||
|
2024
Q1 | $2.17M | Sell |
|
|||||
|
2023
Q4 | $21.1M | Sell |
|
|||||
|
2023
Q3 | $18M | Buy |
|
|||||
|
2023
Q2 | $8.5M | Sell |
|
|||||
|
2023
Q1 | $7.41M | Sell |
|
|||||
|
2022
Q4 | $19.7M | Sell |
|
|||||
|
2022
Q3 | $22.1M | Sell |
|
|||||
|
2022
Q2 | $23.3M | Buy |
|
|||||
|
2022
Q1 | $20.9M | Buy |
|
|||||
|
2021
Q4 | $11.7M | Buy |
|
|||||
|
2021
Q3 | $877K | Sell |
|
|||||
|
2021
Q2 | $1.58M | Sell |
|
|||||
|
2021
Q1 | $1.59M | Sell |
|
|||||
|
2020
Q4 | $2.43M | Sell |
|
|||||
|
2020
Q3 | $7.88M | Sell |
|
|||||
|
2020
Q2 | $10.3M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $3.46M | Buy |
|
|||||
|
2019
Q1 | $1.04M | Buy |
|
|||||
|
2018
Q4 | $661K | Buy |
|